Literature DB >> 6125416

Mechanisms of hormone receptor-effector coupling: the beta-adrenergic receptor and adenylate cyclase.

R J Lefkowitz, M G Caron, T Michel, J M Stadel.   

Abstract

The beta-adrenergic receptors that are coupled to adenylate cyclase have provided a model system for studying the mechanisms by which a plasma membrane receptor is coupled to a well-defined biochemical effector. The beta 2-adrenergic receptors from frog erythrocyte membranes have been purified to homogeneity and the ligand-binding subunit has been identified as a glycoprotein with an approximate molecular weight of 58,000. This subunit has also been identified with the use of newly developed photoaffinity reagents. Under the influence of agonist hormones (H), the receptors (R) form transient complexes with another component of this system, termed the nucleotide regulatory protein (N). Formation of this ternary complex, HRN, leads to the dissociation of GDP from N and the interaction of stimulatory GTP with N. N charged with GTP appears to activate the catalytic moiety of the adenylate cyclase enzyme. Although some striking analogies have been found for the mechanisms by which inhibitory receptors interact with adenylate cyclase, much less is known about the molecular properties of the components involved and the ways in which they interact to dampen adenylate cyclase activity in the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125416

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  14 in total

1.  Sites of interactions of surfactants with beta-adrenergic responses in trout (Salmo gairdneri) gills.

Authors:  R M Stagg; T J Shuttleworth
Journal:  J Comp Physiol B       Date:  1987       Impact factor: 2.200

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

Review 4.  Gaq proteins: molecular pharmacology and therapeutic potential.

Authors:  Danielle Kamato; Partha Mitra; Felicity Davis; Narin Osman; Rebecca Chaplin; Peter J Cabot; Rizwana Afroz; Walter Thomas; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2016-11-04       Impact factor: 9.261

5.  The beta-adrenoceptor-adenylate cyclase complex. From model to biochemical reality.

Authors:  A P Ijzerman; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1986-08-22

6.  Activation-specific interactions among B-lymphocyte plasma membrane proteins.

Authors:  M G Goodman; R L Wolfert
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

7.  A redox cycling model for the action of beta-adrenoceptor agonists.

Authors:  P W Kühl
Journal:  Experientia       Date:  1985-09-15

Review 8.  Receptors: the materialization of a concept.

Authors:  E J Ariëns
Journal:  Pharm Weekbl Sci       Date:  1983-08-26

9.  A molecular graphics study exploring a putative ligand binding site of the beta-adrenoceptor.

Authors:  A P IJzerman; H W van Vlijmen
Journal:  J Comput Aided Mol Des       Date:  1988-04       Impact factor: 3.686

10.  Binding of agonists and antagonists to beta-adrenoceptors in rat vas deferens: relationship to functional response.

Authors:  J M May; P W Abel; K P Minneman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.